(THE CONVERSATION) ChatGPT burst onto the technology world, gaining 100 million users by the end of January 2023, just two months after its launch and bringing with it a looming sense of change.

Revenue for Q3 2025 reached $72.6 million, with a GAAP gross margin of 43.8%, up 230 basis points sequentially. Adjusted EBITDA was $4.7 million, marking a $5 million improvement from the previous ...

Please view our affiliate disclosure. The rise of artificial intelligence (AI) has led to a wide range of incredible text to speech (TTS) generators and tools. Text to speech is a speech synthesis ...

In a big relief to Chief Minister Siddaramaiah, the Karnataka High Court has refused to transfer the probe into the land scam case linked to the Mysuru Urban Development Authority (MUDA) to the ...

If you’ve typed up a long text message on your smartphone, you will know that smartphone keyboards can sometimes be finicky. The keyboard may be sluggish, or your fingers might be too large for ...

Assessment of Rare Cancers and Sarcoma Policy and Sarcoma Drug Approvals in Latin America: A Report From the LACOG Sarcoma Group All AYA OGS and ES cases treated at our institute with OGS-12 and Ewing ...

Yes. What we've tried not to do, Nehal, I hope you're doing well, is talk about our customers' business. I'll let Dan talk about who we're displacing in. But obviously, all 3 of those wins were ...

They can even make it look like a legitimate organisation is contacting you via text or a messaging app by using identity masking technology to change the name displayed as the sender. This is known ...

10 Nehal Vadoliya Web Series in 2025 (18+ Only): Actress Nehal Vadoliya is well known for her work in television shows and films. In 2018, she made her acting debut in the Gujarati film “Gujarati ...

This case report describes the clinical journey of a male patient in early childhood with developmental delay, failure to thrive, worsening right-sided head tilt torticollis and regression of motor ...

A phase 1/2 study to evaluate CHM-2101, an autologous cadherin 17 (CDH17) chimeric antigen receptor (CAR) T cell therapy for the treatment of relapsed or refractory gastrointestinal cancers. Phase 1/2 ...